4.6 Article

Identification of new 4-(6-oxopyridazin-1-yl)benzenesulfonamides as multi-target anti-inflammatory agents targeting carbonic anhydrase, COX-2 and 5-LOX enzymes: synthesis, biological evaluations and modelling insights

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments

Mahmoud A. Ragab et al.

Summary: In the current medical era, the traditional single target inhibition paradigm of drug discovery is being replaced by the multi-target design concept. A novel series of 4-(5-amino-pyrazol-1-yl)benzenesulfonamide derivatives was designed and synthesized as potential multi-target anti-inflammatory agents. The compounds showed inhibitory activities against COX-2, 5-LOX, and carbonic anhydrase (CA) isoforms, suggesting their potential application in treating inflammatory diseases with a multi-target approach.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Chemistry, Medicinal

Anti-inflammatory activity of pyridazinones: A review

Marwa S. A. Hassan et al.

Summary: The pyridazinone core is an important structure in the field of anti-inflammation, offering low ulcerogenic effects. Its easy functionalization at various ring positions makes it an attractive target for synthesis and therapy. This review provides an overview of recent advances in pyridazinone derivatives as potential anti-inflammatory agents, offering insights into the rational design of more effective anti-inflammatory pyridazinones.

ARCHIV DER PHARMAZIE (2022)

Article Biochemistry & Molecular Biology

Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity

Niccolo Cantini et al.

Summary: Persistent inflammation contributes to various diseases. A study identified a range of compounds with anti-inflammatory activity, some of which act as FPR agonists while others inhibit inflammation through different signaling pathways. Further research is needed to define the molecular targets of these compounds and their relationship to FPR signaling.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities

Asmaa H. H. Ahmed et al.

Summary: A series of novel pyrazole-chalcone analogs of Lonazolac were synthesized and investigated for their in vitro anticancer and anti-inflammatory activities. Among them, hybrid 8g showed the most potent inhibitory activity against three cancer cell lines and displayed promising inhibitory activity towards various targets, suggesting it as a potential candidate for cancer prevention and treatment.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR

Minakshi A. Meshram et al.

Summary: Inflammation is a complex pathological process leading to various diseases, with different treatments available but limitations exist. The development of new, effective, and safe anti-inflammatory agents is needed to address the shortcomings of current treatments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences

Stephen K. Burley et al.

Summary: RCSB PDB, as the US data center for the global PDB archive, provides free access to 3D macromolecular structure data for millions of users worldwide, including educators, students, and the general public, integrating over 40 external biodata resources. The redesigned website now features improved search functionality and easier access to PDB data, showcasing new structures relevant to the understanding and addressing of the COVID-19 pandemic.

NUCLEIC ACIDS RESEARCH (2021)

Article Chemistry, Medicinal

Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors

Moataz Shaldam et al.

Summary: This study describes the design of benzofuran-based derivatives as potential carbonic anhydrase inhibitors, with modifications in tail and spacer structures to enhance inhibitory activities against tumor-related CA isoforms. The synthesized compounds showed efficient inhibition of CA IX isoform and promising anticancer and pro-apoptotic activities towards cancer cell lines.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development

Mudasir Nabi Peerzada et al.

Summary: Heterocyclic scaffolds are widely used in drug design to target therapeutic molecules related to a variety of diseases, including tumors. Optimized molecular hybridization of these scaffolds may lead to the discovery of more effective anticancer therapeutics and prevent resistance development by specific targets.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Biochemistry & Molecular Biology

An overview on the recently discovered iota-carbonic anhydrases

Alessio Nocentini et al.

Summary: Carbonic anhydrases (CAs) are a versatile enzyme superfamily involved in multiple physiological processes, and recent discoveries have revealed a new type of iota-CAs with unique catalytic activity without the need for metal ions.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders

Claudiu T. Supuran

Summary: Carbonic anhydrases are enzymes involved in various diseases, and their inhibitors are used in clinical drugs for a range of conditions. In recent years, multitargeting approaches combining CA inhibitors with other types of drugs have shown enhanced efficacy, making them a promising strategy for pharmacological applications.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases

Majid Ali et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Medicinal

Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer

Wagdy M. Eldehna et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Review Biochemistry & Molecular Biology

Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment

Andrea Angeli et al.

METABOLITES (2020)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamidesAQ3 as carbonic anhydrase isoforms I and II inhibitors

Mohammad M. Al-Sanea et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents

Chantal Barberot et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach

Jaismy P. Jacob et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Review Chemistry, Medicinal

Pyridazinone: an attractive lead for anti-inflammatory and analgesic drug discovery

Jyoti Singh et al.

FUTURE MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Synthesis and Anticancer Studies of Novel N-benzyl Pyridazino ne Derivatives

Mohamed Elagawany et al.

LETTERS IN DRUG DESIGN & DISCOVERY (2017)

Review Biochemistry & Molecular Biology

How many carbonic anhydrase inhibition mechanisms exist?

Claudiu T. Supuran

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649)

Hyun Tae Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

Structure and function of carbonic anhydrases

Claudiu T. Supuran

BIOCHEMICAL JOURNAL (2016)

Article Chemistry, Medicinal

Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors

Raed Yaseen et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Review Chemistry, Medicinal

The therapeutic journey of pyridazinone

Wasim Akhtar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium

Francesca Margheri et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)

Review Chemistry, Medicinal

Recent Advances in Anti-inflammatory Potential of Pyridazinone Derivatives

Minaxi Saini et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX

Janis Leitans et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

α-Carbonic Anhydrases Possess Thioesterase Activity

Muhammet Tanc et al.

ACS MEDICINAL CHEMISTRY LETTERS (2015)

Review Pharmacology & Pharmacy

Multi-target approach for natural products in inflammation

Andreas Koeberle et al.

DRUG DISCOVERY TODAY (2014)

Article Chemistry, Medicinal

Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors

Mohamed Elagawany et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Review Pharmacology & Pharmacy

Shifting from the single to the multitarget paradigm in drug discovery

Jose L. Medina-Franco et al.

DRUG DISCOVERY TODAY (2013)

Letter Pharmacology & Pharmacy

Acetic acid induced painful endogenous infliction in writhing test on mice

Shivaji P. Gawade

JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2012)

Review Biochemistry & Molecular Biology

Regulation of inflammation in cancer by eicosanoids

Emily R. Greene et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)

Article Biochemical Research Methods

Atomic resolution studies of carbonic anhydrase II

Craig A. Behnke et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Orthopedics

The association of spinal osteoarthritis with lumbar lordosis

Michael Papadakis et al.

BMC MUSCULOSKELETAL DISORDERS (2010)

Review Pharmacology & Pharmacy

Carbonic anhydrases - An overview

Claudiu T. Supuran

CURRENT PHARMACEUTICAL DESIGN (2008)

Article Multidisciplinary Sciences

Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells

DA Whittington et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)